Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 11/25/2014 6:57:00 PM - Followers: 1119 - Board type: Free - Posts Today: 0
PostSubject
#184160  Sticky Note Sort of OT re $GILD and $ABBV: Rocky3 11/25/14 02:15:41 PM
#184157  Sticky Note Former RTRX CEO is a con man: DewDiligence 11/25/14 01:00:12 PM
#184152  Sticky Note ESRX continues to bang the drum in effort DewDiligence 11/25/14 11:30:21 AM
#184150  Sticky Note MDGN -13% on sale of 5.9M* shares @$4.10 DewDiligence 11/25/14 11:22:10 AM
#184143  Sticky Note Why independent oncology practices are a dying breed (NYT): DewDiligence 11/24/14 11:20:24 AM
#184134  Sticky Note Re: ENTA’s cash balance and liquidity DewDiligence 11/24/14 08:45:04 AM
#184161   FOLD hit 52wk high today on the right kei 11/25/14 06:57:00 PM
#184160   Sort of OT re $GILD and $ABBV: Rocky3 11/25/14 02:15:41 PM
#184158   He plans to raise the cost of the oldberkeley 11/25/14 01:24:51 PM
#184157   Former RTRX CEO is a con man: DewDiligence 11/25/14 01:00:12 PM
#184156   Brad Loncar’s blog on FPRX (which you presumably mcbio 11/25/14 12:31:54 PM
#184155   Brad Loncar’s blog on FPRX (which you presumably DewDiligence 11/25/14 12:17:32 PM
#184153   FPRX, BMY > Bristol-Myers Squibb and Five Prime mcbio 11/25/14 11:40:45 AM
#184152   ESRX continues to bang the drum in effort DewDiligence 11/25/14 11:30:21 AM
#184151   The IBD article on ENTA is devoid of DewDiligence 11/25/14 11:24:51 AM
#184150   MDGN -13% on sale of 5.9M* shares @$4.10 DewDiligence 11/25/14 11:22:10 AM
#184148   Can Partnering To Fight Hepatitis C Pay At Enanta? masterlongevity 11/24/14 07:10:08 PM
#184147   Biotech Values survey #154 (from 12/25/13) can now DewDiligence 11/24/14 05:17:54 PM
#184146   JNJ becomes the newest player in CAR-T: DewDiligence 11/24/14 02:51:03 PM
#184144   LUN Lundbeck CEO Leaves After Failing to Report JohnWayne 11/24/14 12:47:12 PM
#184143   Why independent oncology practices are a dying breed (NYT): DewDiligence 11/24/14 11:20:24 AM
#184142   $rna Congrats to iwfal masterlongevity 11/24/14 11:04:36 AM
#184141   FPRX, BMY > Bristol-Myers Squibb and Five Prime biocqr 11/24/14 11:02:09 AM
#184140   Why These Big Pharma Stocks Could Plunge Next Year Preciouslife1 11/24/14 09:49:38 AM
#184139   >>We now know the lower the LDL the biomaven0 11/24/14 09:38:37 AM
#184138   AMGN terminates phase-3 trials of rilotumumab* due to DewDiligence 11/24/14 09:22:28 AM
#184137   MRK, NLNK ink collaboration for Ebola vaccine: DewDiligence 11/24/14 09:12:26 AM
#184134   Re: ENTA’s cash balance and liquidity DewDiligence 11/24/14 08:45:04 AM
#184133   Recent Biotech Buyouts of Publicly Traded Companies DewDiligence 11/24/14 08:22:05 AM
#184132   BioMarin buys Prosensa for up to $840M, shoots hptaxis 11/24/14 07:37:24 AM
#184131   Deutsche Bank initiates Regulus Therapeutics $RGLS with Buy, Double_Bagel 11/24/14 06:27:59 AM
#184130   New OHAD blog on CLVS (& FMI) Double_Bagel 11/23/14 01:51:44 PM
#184129   China plans another rate cut on fears of bladerunner1717 11/23/14 01:12:03 PM
#184128   CLDX - With the latest ReACT data release, hirogen 11/23/14 10:23:45 AM
#184127   We now know the lower the LDL kamehameha 11/23/14 09:10:55 AM
#184126   ENTA has an early-stage antibiotic :- ) DewDiligence 11/22/14 01:27:49 PM
#184125   From Wells (not exactly from the same report Rocky3 11/22/14 11:41:53 AM
#184123   ESPR—Understood that long-term safety of ETC-1002 remains a DewDiligence 11/22/14 10:41:05 AM
#184122   Roche is going to buy something else if jq1234 11/21/14 10:30:07 PM
#184121   >> We now know the lower the LDL jq1234 11/21/14 10:13:51 PM
#184120   Why would MRK buy a drug that's still guerlain 11/21/14 08:31:09 PM
#184119   EYES -10% today, but +135% from IPO price DewDiligence 11/21/14 07:06:02 PM
#184118   If you were Roger Perlmutter, would you pull DewDiligence 11/21/14 07:00:19 PM
#184117   TTPH +22% AH on buyout chatter: DewDiligence 11/21/14 06:51:10 PM
#184116   Stifel picks in small-cap biotech bladerunner1717 11/21/14 03:37:28 PM
#184115   My ENTA valuation model (#msg-94993406) assumes ABBV/ENTA’s 3-DAA stockbettor 11/21/14 03:07:15 PM
#184114   to paraphrase a prominent cardiologist: CETP inhibitors jellybean 11/21/14 02:59:27 PM
#184113   If I were Merck, I would buy ESPR, DewDiligence 11/21/14 01:58:16 PM
#184112   We now know the lower the LDL the jellybean 11/21/14 01:53:19 PM
#184111   As you know, in the ‘008’ study high-dose DewDiligence 11/21/14 01:38:13 PM
#184110   What do you think the LDL lowering range jellybean 11/21/14 01:21:38 PM
#184109   Enta is/was also a thin traded stock and linhdtu 11/21/14 12:58:57 PM
#184108   Re: genotype / sub-type ciotera 11/21/14 12:58:30 PM
#184107   ENTA—...with approval baked into the price, what will DewDiligence 11/21/14 12:54:34 PM
#184106   FMI’s 3Q14 CC was more than two weeks DewDiligence 11/21/14 12:50:21 PM
#184105   Bought 3K more today. My target is to linhdtu 11/21/14 12:49:01 PM
PostSubject